This white paper systematically organizes the mechanism of Chienomoto's core ingredients, trends from 230 real-world observation cases, and the multi-center prospective clinical research currently underway; by reviewing externally published literature alongside internal empirical data, it clarifies Chienomoto's positioning as a "state optimizer" within the broader neurological rehabilitation system, along with the boundaries of its supporting evidence.
White Paper Highlights
Chienomoto uses a multi-target, progressive synergistic formula, with core ingredients including:
Ferulic Acid (FA): Anti-neuroinflammatory and antioxidant, stabilizing the neural microenvironment
Angelica Dahurica (Bai Zhi) Extract: Works synergistically to improve cerebral blood perfusion
Phosphatidylserine (PS): Maintains neuronal cell membranes, supporting attention and short-term memory
Pyrroloquinoline Quinone (PQQ): Promotes mitochondrial energy metabolism
Real-world observation of 230 cases shows: a 72% overall improvement feedback rate at 1 month, with sleep/mood improving first within 1 week, attention improving at 2–4 weeks, and cognition and language gradually improving at 4–8 weeks.
"State Optimizer" Positioning
Chienomoto is not a substitute for pharmaceutical treatment, but rather provides long-term, stable brain-nutrition support for frontal lobe functions (mood, sleep, attention, memory, cognition, and language). It is suited for use within a comprehensive neurological rehabilitation system, as a "state optimizer" that works alongside other interventions.
This white paper also clearly defines the boundaries of evidence for Chienomoto — identifying which directions are already well-supported by evidence, and which still require further validation through more high-quality research. Through this candid presentation of evidence, we hope to work together with clinicians, rehabilitation therapists, and parents to advance the scientific understanding of frontal-lobe nutritional support.
The full white paper is available in text-and-image / PDF format — please click the button below to access it.
Read the Full White Paper →
Request PDF Version
